Kazakhstan Medical Device Inspection Readiness: Building a Site-Ready Compliance Pack

1. Key takeaways

Supervisory inspections in Kazakhstan and Union-side manufacturing inspections (Decision No. 106) share a common methodological baseline: the quality management system is evaluated by process. The recommendations adopted by the Eurasian Economic Commission Executive Committee on April 7, 2026 define the evaluated processes as five items: design and development (if included in the QMS), documentation and records management, production and release control, corrective and preventive actions, and consumer-related processes. They also specifically flag sterilization processes for attention, and manufacturing site inspections when notices of adverse events or complaints are received. The effective way to face an inspection is to prepare a compliance pack that can be retrieved on site, rather than searching through files at the last minute.

2. Legal basis

3. Expert insights

Insight 1: although the Executive Committee recommendation of April 7, 2026 is advisory, it in practice defines the inspection standard. The document provides a common methodological baseline for inspection authorities across the Union member states, breaking the inspection content down into specific tasks according to risk level and whether a QMS has been certified. It particularly emphasizes sterilization processes and manufacturing site inspections when notices of adverse events or product complaints are received. Although not mandatory, it in practice shapes the direction of inspection preparation for every manufacturer selling into the region. Treating the advisory text as a preparation checklist is the pragmatic reading, because inspectors trained on it will ask along its structure.

Insight 2: the compliance pack should be organized by process, not by department. Inspectors ask questions along the five processes: design and development, documentation and records, production and release control, corrective and preventive actions, and consumer-related processes. Filing the pack under these five categories lets the inspector obtain the required material in the shortest time, and it also lets the company itself discover which category contains a gap before the inspector does. A short self-assessment against the five categories each quarter keeps the pack aligned with the actual state of the system.

Insight 3: an ISO 13485 certificate narrows the inspection scope but not the preparation scope. Under Decision No. 106, where an equivalent ISO 13485 certificate and audit report are available, the inspection may be limited to three processes: design and development, production and release control, and consumer-related processes. The company still needs complete evidence for those three processes; it is only the documentation management process that usually ceases to be a focus of the inspection. The certificate and the audit report should be current, since an expired or scoped-down document invites the very questions it was meant to avoid.

Insight 4: sterilization is the high-attention area named in the 2026 recommendation. Sterilization validation for sterile devices, routine monitoring, deviation handling and revalidation records are the objects of frequent questioning during inspections. This area is also a focus in most audits in the country of origin, but the angle of questioning on the Kazakhstan and Union side differs, particularly in its linkage to adverse events and complaints received from the market. Keeping complaint records physically close to sterilization records in the pack makes that linkage easy to demonstrate.

Insight 5: the value of the compliance pack lies in ordinary days, not on inspection day. Being able to produce material on inspection day depends on filing it in a searchable way during routine work. The approach of GRZAN is to maintain the pack as an indexed loose-leaf binder that is updated continuously and taken directly into the inspection when the day arrives, so nothing depends on last-minute assembly under time pressure. The index itself should name the document owner for each category, so that a missing item can be produced by the right person rather than by whoever happens to be present.

4. Practical recommendations

1. File the compliance pack by the five processes: design and development, documentation and records, production and release control, corrective and preventive actions, and consumer-related processes.
2. Keep sterilization validation, routine monitoring, deviation handling and revalidation records in a separate volume for rapid retrieval.
3. Where an ISO 13485 certificate exists, have the certificate and audit report ready to narrow the inspection scope, but keep the evidence for the three key processes complete.
4. Build a traceability chain from complaints and adverse events to the manufacturing site, answering the second focus of the 2026 recommendation.
5. Maintain the compliance pack as an indexed loose-leaf that is updated in routine work and taken directly into the inspection.

5. Verification checklist

• □ The compliance pack has been filed by the five processes and carries an index
• □ Sterilization validation, routine monitoring, deviation handling and revalidation records have been kept in a separate volume
• □ The ISO 13485 certificate and audit report have been prepared
• □ A traceability chain from complaints and adverse events to the manufacturing site has been established
• □ A responsible owner has been designated to maintain and update the compliance pack at fixed intervals
• □ The 3-year validity of inspection reports has been entered into a rolling calendar

Regulatory information verified as of October 29, 2026.

GRZAN provides registration and post-market compliance support for medical device manufacturers, importers and authorized representatives in Kazakhstan, including compliance pack assembly, inspection readiness assessment and on-site support. For inquiries, contact info@grzanglobal.com.